Freda Lewis-Hall
Showing 1–12 of 12 transcripts.
- Milken Institute1h 1m
Healthy Longevity: New Strategies for a New Normal
Nora Super, Freddy Abnousi, Richard Ashworth, Anna Dixon, Freda Lewis-Hall
The Milken Institute Center for the Future of Aging convened leaders to examine how the pandemic exacerbated age-related health inequities while accelerating a permanent shift toward digital fitness and telehealth. Speakers highlighted persistent disparities in life expectancy driven by social determinants like housing quality and internet access, noting that systemic barriers outweigh individual responsibility in shaping outcomes. The session concluded that sustainable healthy aging strategies must integrate personalized technology with structural policy reforms to address decades of accumulated disadvantage.
- Milken Institute48 min
Building the Mental Health System We Need
Robert Wilkie, Freda Lewis-Hall, Kay Jamison, Ronald Kessler, Robert Nelsen, Richard Pops, Brandon Staglin, Ron Kessler, Bob Nelson, Shawmi Finless
Current mental health systems struggle with diagnostic ambiguity and payment barriers that leave one in five Americans untreated, resulting in premature mortality and a $3 trillion global economic burden. To address these systemic failures, experts propose shifting from subjective symptom scales to a data-driven framework utilizing passive monitoring and quantitative biomarkers for early, personalized intervention. This approach aims to expand access to Coordinated Specialty Care, accelerate drug approval through regulatory reform, and integrate workforce innovations to break the cycle of chronic disease and incarceration.
- Milken Institute53 min
The Cost of Chronic Disease and the Future of Treatment
Hugh Waters, Hawaa Althahak Almansoori, Sumit Jamuar, Nancy Knight, Freda Lewis-Hall, Hawa Al-Mansouri
The event examines the escalating chronic disease crisis in the MENA region, where obesity and diabetes rates now rival US figures, driving a $20.5 billion economic burden and necessitating advanced mobile surveillance strategies. Experts highlight critical gaps in genomic data representation and clinical reference ranges that risk misdiagnosing non-European populations, while detailing how falling sequencing costs and AI are enabling precision medicine. The panel concludes by advocating a systemic shift from reactive sick care to proactive health systems that prioritize lifestyle modification and predictive prevention to mitigate future disease burdens.
- Milken Institute58 min
Women's Health: Addressing Disparities from Health Leadership to Patient Care
Joanne Kenen, Janine Austin Clayton, Isabella Danel, Freda Lewis-Hall, Saralyn Mark, Paula Schneider
A panel of high-level health leaders from Pfizer, NIH, and the Susan G. Komen foundation highlighted the persistent gap between women's 57% share of U.S. healthcare expenses and their underrepresentation as decision-makers in clinical research. Participants argued that moving beyond a narrow reproductive focus to a holistic model addressing social determinants like violence and poverty requires integrating sex and gender data into all phases of biomedical innovation, from drug trials to medical device design. The group concluded that achieving equity demands structural changes, including formal male sponsorship, expanded parental leave, and the adoption of gendered innovations to ensure health systems serve diverse populations effectively.
- Milken Institute1h 2m
Solving Life-Threatening Problems in Oncology
Howard Soule, Rajiv Kaul, Freda Lewis-Hall, David Reese, Mark Simon, Howard Sewell
A panel of industry leaders including Pfizer's Dr. Freda Lewis-Hall and Amgen's David Reese examines the paradox of skyrocketing NIH funding and precision oncology breakthroughs against persistent barriers like clinical trial rigidity and healthcare inequities. The discussion highlights the disconnect between advanced "Star Wars" level treatments and outdated delivery systems, calling for regulatory agility and patient-centric trial designs to address the 2.1-fold increase in cancer-related bankruptcies. Ultimately, the experts urge a systemic shift toward democratizing access to genomic diagnostics and prioritizing quality-of-life endpoints over traditional longevity metrics.
- Milken Institute58 min
Patients: The New Economy of Healthcare
Cynthia Grossman, David Feinberg, Jen Horonjeff, Freda Lewis-Hall, Michael Loeb, Jessica Mega, Cindy Grossman
Addressing a healthcare system where 18% of US GDP is spent with inferior life expectancy outcomes, industry leaders from Pfizer, Geisinger, Verily, and Savvy Cooperative advocate a structural shift toward patient-centric B2P models. These initiatives leverage data democratization, anticipatory medicine, and direct pharmacy discounts to decouple revenue from volume while integrating social determinants of health into clinical care. This transformation aims to eliminate systemic friction and replace traditional waiting rooms with home-based, outcome-driven services that prioritize "years lived well" over mere enrollment metrics.
- Milken Institute1h 0m
Prescription for a Longer (and Healthier) Life
Paul Irving, Freda Lewis-Hall, Becca Levy, Loretta DiPietro, Patricia Boyle, Jeff Hogan, Byron Boston, Laura Ladd
Experts advocating a lifelong "platform" model for healthy aging emphasize that positive age stereotypes and a sense of purpose can extend survival by 7.5 years and significantly delay cognitive decline. Despite these findings, systemic barriers such as a medical budget skewed 90% toward treatment and a three-decade gap in public perception hinder the adoption of preventive strategies. To overcome these challenges, leaders recommend integrating early education on aging, designing age-neutral communities, and accelerating the translation of scientific data into immediate policy shifts.
- Milken Institute1h 18m
Public Health, Medical Research and the Cancer Moonshot: A Collaboration to Change the World
Michael Milken, Francis Collins, Linda Fried, Robert Hugin, Freda Lewis-Hall
Vice President Biden and medical leaders are launching a strategic "Cancer Moonshot" to overcome siloed research through a $680 million federal investment and the Precision Medicine Initiative's enrollment of one million Americans. The framework prioritizes seven key themes, including early detection blood tests, single-cell analysis, and public-private partnerships modeled after the Accelerating Medicines Partnership, while explicitly warning against overpromising a timeline for a universal cure. Parallel to the National Institutes of Health and FDA funding, the initiative integrates public health science to address prevention drivers and leverages global data collaboration to accelerate the shift toward data-driven, individualized cancer therapies.
- Milken Institute46 min
A Future of Healthy Aging
Paul Irving, Pinchas Cohen, Linda Fried, Freda Lewis-Hall, Robin Mockenhaupt
A global panel convened to address the critical misalignment between rising life expectancy and stagnant healthspan, framing older adults as an underutilized human capital asset essential for the 21st-century economy. The discussion highlighted that delaying Alzheimer's onset by five years could halve annual caregiving costs and proposed a "Frieden's Triangle" strategy combining genomic risk assessment, social engagement programs, and targeted public health policies to transform prevention. To realize this vision, the group advocated for a "third demographic dividend" through a tenfold increase in federal funding, clinical trial reforms for geriatric populations, and the creation of new social institutions designed specifically for the emerging thirty-year life stage.
- Milken Institute1h 1m
Prescription for Wellness: Extending Our Health Span
Hossie Cohen, Freda Lewis-Hall, Yves Joannet, Paul Irving, Steve Bird, Lynn Goldman, Mike McDonald Jr.
Panelists at this gathering analyzed the widening gap between increased life expectancy and stagnant health spans, highlighting the rising economic and societal burden of chronic conditions like Alzheimer's in rapidly aging global populations. Experts outlined emerging biomedical strategies, including precision genomics and preventive interventions, while emphasizing the urgent need to shift funding from curative care to early prevention to mitigate projected trillions in future healthcare costs. The discussion further stressed that overcoming these challenges requires systemic changes in urban planning, employer policies, and insurance incentives to address behavioral barriers and social determinants that currently hinder effective aging outcomes.
- Milken Institute1h 0m
Secrets to a Healthy Life: Freda Lewis-Hall and Pattie Sellers
Freda Lewis-Hall, Pattie Sellers, Seth Ginsburg
During discussions regarding a potential $100 billion Pfizer-AstraZeneca merger, Chief Medical Officer Frida Lewis-Hall outlined her role in overseeing global patient safety and clinical data integrity while addressing the healthcare system's critical fragmentation. She advocates for a shift toward individualized health management where patients act as "CEOs" of their own medical records to bridge gaps in continuity, emphasizing specific metrics like waist circumference and the need for comprehensive family history. Looking ahead, Lewis-Hall calls for intensified collaboration across the public and private sectors to combat the looming economic crisis of Alzheimer's disease and to integrate AI-driven diagnostics into preventative care strategies.
- Milken Institute1h 3m
Innovators on the Front Lines of the Future
Paul Benda, Freda Lewis-Hall, Megan Smith, Peter Diamandis
Following the XPRIZE Visioneering event, a panel of twelve domain experts finalized ten high-impact prize concepts ranging from happiness gamification to rapid vaccine production and global literacy. Key initiatives include Nicolas Negroponte's $15 million literacy challenge, Tony Robbins' behavior-change prize grounded in Martin Seligman's data, and a $5 million diversity-focused X2 Prize funded by Lynn Tilton. These competitions aim to disrupt traditional R&D models by leveraging private funding and regulatory incentives to solve complex global problems like Alzheimer's diagnostics, atmospheric water extraction, and homeland security screening.